Gil Schwartzberg - Director, 10%+ Owner at Lixte Biotechnology Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Stock Symbol
LIXT, LIXTW on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Gil Schwartzberg since 12/26/2023

Holdings reported by Gil Schwartzberg for Lixte Biotechnology Holdings, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 376K $944K $2.51 Dec 31, 2021 By Gil & Debbie Schwartzberg Family Trust, Gil Schwartzberg Separate Property
Common Stock 216K $542K $2.51 Sep 3, 2021 Direct
Common Stock 192K $481K $2.51 Dec 31, 2021 By David N. Sterling Trust
Common Stock 187K $469K $2.51 Dec 31, 2021 By Julie Schwartzberg Trust
Common Stock 106K $267K $2.51 Dec 31, 2021 By Continuum Partners, L.P.
Common Stock 33.3K $83.7K $2.51 Dec 31, 2021 By Julie Forman 2013 Trust
Common Stock 16.7K $41.8K $2.51 Dec 31, 2021 By Amanda Sterling Trust
Common Stock 16.7K $41.8K $2.51 Dec 31, 2021 By Charles Sterling Trust
Common Stock 16.7K $41.8K $2.51 Dec 31, 2021 By Daniel Sterling Trust
Common Stock 16.7K $41.8K $2.51 Dec 31, 2021 By Savannah Sterling Trust

Transactions reported by Gil Schwartzberg for Lixte Biotechnology Holdings, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.